"CD30 Ligand" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A membrane-bound tumor necrosis family member found primarily on activated T-LYMPHOCYTES that binds specifically to CD30 ANTIGEN. It may play a role in INFLAMMATION and immune regulation.
| Descriptor ID |
D053285
|
| MeSH Number(s) |
D12.644.276.374.750.092 D12.776.395.550.177 D12.776.467.374.750.092 D12.776.543.550.196 D23.529.374.750.092
|
| Concept/Terms |
CD30 Ligand- CD30 Ligand
- CD153 Antigens
- Tumor Necrosis Factor Ligand Superfamily Member 8
- TNF Superfamily, Member 8
- CD153 Antigen
- Antigen, CD153
- Antigens, CD153
|
Below are MeSH descriptors whose meaning is more general than "CD30 Ligand".
Below are MeSH descriptors whose meaning is more specific than "CD30 Ligand".
This graph shows the total number of publications written about "CD30 Ligand" by people in this website by year, and whether "CD30 Ligand" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD30 Ligand" by people in Profiles.
-
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. J Immunol. 2017 08 01; 199(3):974-981.
-
Evaluation of NF-?B subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions. Mod Pathol. 2015 Sep; 28(9):1202-13.
-
Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
-
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Br J Haematol. 2006 Feb; 132(4):503-11.
-
CD30 ligand in lymphoma patients with CD30+ tumors. J Clin Oncol. 1997 Nov; 15(11):3355-62.
-
CD30 ligand is expressed on resting normal and malignant human B lymphocytes. Br J Haematol. 1996 Jun; 93(3):569-71.
-
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 1993 Jul 02; 73(7):1349-60.